Adalimumab for the treatment of ankylosing spondylitis
Authors:
- 11 April 2007
- journal article
- Published by Informa Healthcare in Expert Opinion on Pharmacotherapy
- Vol. 8 (6) , 831-838
Abstract
(2007). Adalimumab for the treatment of ankylosing spondylitis. Expert Opinion on Pharmacotherapy: Vol. 8, No. 6, pp. 831-838.Keywords
This publication has 35 references indexed in Scilit:
- No efficacy of subcutaneous methotrexate in active ankylosing spondylitis: a 16-week open-label trialAnnals of the Rheumatic Diseases, 2007
- Efficacy of sulfasalazine in patients with inflammatory back pain due to undifferentiated spondyloarthritis and early ankylosing spondylitis: a multicentre randomised controlled trialAnnals of the Rheumatic Diseases, 2006
- Concepts and epidemiology of spondyloarthritisBest Practice & Research Clinical Rheumatology, 2006
- ASAS/EULAR recommendations for the management of ankylosing spondylitisAnnals of the Rheumatic Diseases, 2006
- First update of the international ASAS consensus statement for the use of anti-TNF agents in patients with ankylosing spondylitisAnnals of the Rheumatic Diseases, 2006
- Double blind, randomised, placebo controlled study of leflunomide in the treatment of active ankylosing spondylitisAnnals of the Rheumatic Diseases, 2005
- Open label trial of anakinra in active ankylosing spondylitis over 24 weeksAnnals of the Rheumatic Diseases, 2005
- Six months open label trial of leflunomide in active ankylosing spondylitisAnnals of the Rheumatic Diseases, 2005
- Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitisArthritis & Rheumatism, 1995
- Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patientsArthritis & Rheumatism, 1994